Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haubitz

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Klinische Wochenschrift|September 15, 1988
Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor BM Oppermann, M Haubitz, E Quentin, et al.
Clinical and Experimental Immunology|December 12, 2001
Endothelial tissue factor stimulation by proteinase 3 and elastaseM Haubitz, M Gerlach, H J Kruse, et al.
Clinical Nephrology|July 1, 1992
In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapyM Haubitz, B Klöppel, G Lonnemann, et al.
Intensive Care Medicine|May 13, 2008
Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infectionR Brunkhorst, O K Eberhardt, M Haubitz, et al.
Annals of the Rheumatic Diseases|September 16, 2005
Smoking habits in patients diagnosed with ANCA associated small vessel vasculitisM Haubitz, A Woywodt, K de Groot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Cyclophosphamide pulse therapy in Wegener's granulomatosisM Haubitz, U Frei, U Rother, et al.
Clinical Nephrology|March 10, 1998
Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseasesM Haubitz, C Ehlerding, K Kamino, et al.
Nephron|January 1, 1990
Continuous arteriovenous hemofiltration: in vivo functional characteristics and its dependence on vascular access and filter designC J Olbricht, M Haubitz, U Häbel, et al.
Annals of Hematology|May 29, 2004
An improved assay for enumeration of circulating endothelial cellsA Woywodt, C Goldberg, J Scheer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Activation of the acute phase response and complement C3 in patients with IgA nephropathyU Janssen, F Bahlmann, J Köhl, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Klinische Wochenschrift|September 15, 1988
Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor BM Oppermann, M Haubitz, E Quentin, et al.
Clinical and Experimental Immunology|December 12, 2001
Endothelial tissue factor stimulation by proteinase 3 and elastaseM Haubitz, M Gerlach, H J Kruse, et al.
Clinical Nephrology|July 1, 1992
In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapyM Haubitz, B Klöppel, G Lonnemann, et al.
Intensive Care Medicine|May 13, 2008
Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infectionR Brunkhorst, O K Eberhardt, M Haubitz, et al.
Annals of the Rheumatic Diseases|September 16, 2005
Smoking habits in patients diagnosed with ANCA associated small vessel vasculitisM Haubitz, A Woywodt, K de Groot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Cyclophosphamide pulse therapy in Wegener's granulomatosisM Haubitz, U Frei, U Rother, et al.
Clinical Nephrology|March 10, 1998
Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseasesM Haubitz, C Ehlerding, K Kamino, et al.
Nephron|January 1, 1990
Continuous arteriovenous hemofiltration: in vivo functional characteristics and its dependence on vascular access and filter designC J Olbricht, M Haubitz, U Häbel, et al.
Annals of Hematology|May 29, 2004
An improved assay for enumeration of circulating endothelial cellsA Woywodt, C Goldberg, J Scheer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Activation of the acute phase response and complement C3 in patients with IgA nephropathyU Janssen, F Bahlmann, J Köhl, et al.
Pageof 6